Stanford researchers identify means of targeting RBM20 for ameliorating diseased cardiomyocytes Nov. 18, 2021
Preclinical results presented on a novel conditionally activated IFN-alpha INDUKINE molecule Nov. 18, 2021
Novoron secures funding to support development of NOVO-118 for spinal cord injury and MS Nov. 17, 2021
New mouse model allows assessment of HTT mRNA targeting compounds for Huntington's disease Nov. 17, 2021
RSS